Sphygmose Pharmaceutical Private Limited
About Sphygmose Pharmaceutical Private Limited
Data last updated:
Sphygmose Pharmaceutical Private Limited is a private limited company based in Palakkad, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24230KL2012PTC030420. Its GSTIN is 32AARCS1148K1Z4 (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jayasankar Unnikrishnan Cheenikuzhi and Praveen Praveen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Palakkad, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.32 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹3.76 Lakh (net margin -20.5%) and EBITDA of -₹3.72 Lakh (EBITDA margin -20.3%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sphygmose Pharmaceutical Private Limited's registered office is in Palakkad, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRoom No. 10/694(12) 'Classic Tower' Iind Floor Opp. Central Excise Building Mettupalay, Am Street, Palakkad, Kerala, India – 678001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sphygmose Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sphygmose Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sphygmose Pharmaceutical Private Limited, buy the company report.
Financials of Sphygmose Pharmaceutical Private Limited
FY 2025 filings availableSphygmose Pharmaceutical Private Limited reported revenue of ₹18.32 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 12% fall in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -20.3% | ||||
| Net Profit Margin | -20.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sphygmose Pharmaceutical Private Limited, buy the company report.
Board of directors of Sphygmose Pharmaceutical Private Limited
Sphygmose Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayasankar Unnikrishnan Cheenikuzhi | Director | 02 Feb 2012 | 14 Years 8 Months | Current |
| Praveen Praveen | Director | 02 Feb 2012 | 14 Years 8 Months | Current |
Peer comparison
Sphygmose Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A.P. Trading Private Limited | ₹18.33 Lakh (FY 2022) | -28.0% | Kanpur, Uttar Pradesh, India | |||
| Jetic Healthcare Private Limited | ₹18.33 Lakh (FY 2025) | 109.0% | Manpada, Maharashtra, India | |||
| Promom Baby Products Private Limited | ₹18.33 Lakh (FY 2024) | Lucknow, Uttar Pradesh, India | ||||
| Bigturtle Industries (OPC) Private Limited | ₹18.33 Lakh (FY 2025) | -1.0% | Dadri, Uttar Pradesh, India | |||
| Quality Interexpo Private Limited | ₹18.32 Lakh (FY 2018) | -99.0% | Delhi, India | |||
| Sphygmose Pharmaceutical Private Limitedthis company | ₹18.32 Lakh (FY 2025) | -₹3.76 Lakh | -20.5% | -12.0% | Palakkad, Kerala, India | |
| Mohini Agencies Private Limited | ₹18.32 Lakh (FY 2025) | -49.0% | Kolkata, West Bengal, India | |||
| Sri Daamshi Sales & Services Private Limited | ₹18.32 Lakh (FY 2021) | -61.0% | Lucknow, Uttar Pradesh, India | |||
| Lifeserve Healthcare Private Limited | ₹18.32 Lakh (FY 2025) | -18.0% | Beed, Maharashtra, India | |||
| Babuji Overseas Private Limited | ₹18.32 Lakh (FY 2017) | -76.0% | New Delhi, Delhi, India | |||
| Shivangi Vyapar Private Limited | ₹18.31 Lakh (FY 2024) | -82.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Sphygmose Pharmaceutical Private Limited, buy the company report.
Auditor
Sphygmose Pharmaceutical Private Limited is audited by RAMACHANDRAN&RAMACHANDRANASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMACHANDRAN&RAMACHANDRANASSOCIATES | FY 2017 | 005043S |
Shareholding
The shareholding of Sphygmose Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sphygmose Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sphygmose Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sphygmose Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sphygmose Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AARCS1148K1Z4 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sphygmose Pharmaceutical Private Limited, buy the company report.
Recent activity
Sphygmose Pharmaceutical Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Nellampani Ravi Pisharam ceased to be Director on 01 Sep 2021.
Frequently asked questions
Sphygmose Pharmaceutical is an active private limited company based in Palakkad, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 February 2012 (14+ years old) and is registered under CIN U24230KL2012PTC030420.
Sphygmose Pharmaceutical has 2 current directors:
- Jayasankar Unnikrishnan Cheenikuzhi - Director
- Praveen Praveen - Director
The latest financial statements of Sphygmose Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sphygmose Pharmaceutical is 32AARCS1148K1Z4, registered in Kerala.
The CIN (Corporate Identification Number) of Sphygmose Pharmaceutical is U24230KL2012PTC030420. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sphygmose Pharmaceutical was incorporated on 02 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Sphygmose Pharmaceutical by revenue are A.P. Trading Private Limited, Jetic Healthcare Private Limited, Promom Baby Products Private Limited, Bigturtle Industries (OPC) Private Limited, Quality Interexpo Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Nellampani Ravi Pisharam ceased to be Director on 01 Sep 2021. Ajaighosh was appointed as Managing Director on 02 Feb 2012. Jayasankar Unnikrishnan Cheenikuzhi was appointed as Director on 02 Feb 2012. Sphygmose Pharmaceutical has 4 board changes on record in total.
The registered office of Sphygmose Pharmaceutical is at Room No. 1069412 Classic Tower Iind Floor Opp. Central Excise Building Mettupalay, Am Street, Palakkad, Kerala, India – 678001.
Sphygmose Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sphygmose Pharmaceutical is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.